Home Online Features Statement from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, Formerly JDRF, the Leading Global Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts
Statement from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, Formerly JDRF, the Leading Global Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts
Hand-out
Press Releases
February 9, 2025

Statement from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, Formerly JDRF, the Leading Global Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts

By Breakthrough T1D, Formerly JDRF

NEW YORK, Feb. 9, 2025 /PRNewswire/ -- "The announcement from the National Institutes of Health (NIH) that they are dramatically reducing funding for indirect costs for research grants is a

bradford

The Bradford Era

email
Local & Social